John Peter Gutfreund's Insider Trades & SAST Disclosures

John Peter Gutfreund's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 3,564,728 Warrants to Purchase Common Stock done . Disclosure was reported to the exchange on June 30, 2023.

Share

Note

This is a custom search result for pattern John Peter Gutfreund.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Insight Molecular Diagnost...	John Peter Gutfreund	Former Director	Other type of transaction at price $ 0.00 per share.	30 Jun 2023	3,564,728	0	-		-	Warrants to Purchase Common Stock
Insight Molecular Diagnost...	John Peter Gutfreund	Former Director	Other type of transaction at price $ 0.00 per share.	30 Jun 2023	3,085,047	0 (0%)	4%		0	Common Stock, no par value
Insight Molecular Diagnost...	John Peter Gutfreund	Director	Grant, award, or other acquisition of securities at price $ 0.35 per share.	03 Apr 2023	1,000,000	1,075,000 (1%)	1%	0.4	354,400	Common Stock, no par value
Insight Molecular Diagnost...	John Peter Gutfreund	Director	Grant, award, or other acquisition of securities at price $ 0.35 per share.	03 Apr 2023	705,000	715,000 (1%)	1%	0.4	249,852	Common Stock, no par value
Insight Molecular Diagnost...	John Peter Gutfreund	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	03 Apr 2023	588	0	-		-	Series A Convertible Preferred Stock
Insight Molecular Diagnost...	John Peter Gutfreund	Director	Purchase of securities on an exchange or from another person at price $ 0.33 per share.	23 Dec 2022	75,000	75,000 (0%)	0%	0.3	24,728	Common Stock, no par value
Insight Molecular Diagnost...	John Peter Gutfreund	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Aug 2022	45,000	45,000	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	John Peter Gutfreund	Director	Purchase of securities on an exchange or from another person at price $ 0.93 per share.	15 Aug 2022	25,000	25,000 (0%)	0%	0.9	23,250	Common Stock, no par value
Insight Molecular Diagnost...	John Peter Gutfreund	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Aug 2022	10,000	10,000 (0%)	0%		0	Common Stock, no par value

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades